(Q74449512)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

R Ramharack

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M A Spahr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C S Sekerke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R L Stanfield

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R F Bousley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H T Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B K Krause

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

79-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

High degree of genetic polymorphism in apolipoprotein(a) associated with plasma lipoprotein(a) levels in Japanese and Chinese populations

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

The mysteries of lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lipoprotein(a): Nonhuman primate models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lipoprotein Lp(a). A risk factor for myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lipoprotein(a) as a determinant of coronary heart disease in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lipoprotein(a) as a strong indicator for cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lipoprotein [Lp(a)] and peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Testosterone decreases lipoprotein(a) in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Thyroid hormone (fT4) reduces lipoprotein(a) plasma levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Effect of gemfibrozil versus lovastatin on increased serum lipoprotein(a) levels of patients with hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Reduction of Lp(a) plasma levels by bezafibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900189-5

10.1016/S0021-9150(97)00189-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544734%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference